|
Astrocyte NLRP3 inflammasome activation in Parkinsons disease |
5F30AG067643-03 |
|
NIA |
2022 |
|
Effects of apolipoprotein E isoform and amifostine on memory-related DNA double strand breaks and immediate-early gene expression |
1 F31 AG067629-01A1 |
|
NIA |
2021 |
|
Alternative Splicing of ApoER2 in Alzheimers Disease |
1 F31 AG069498-01A1 |
|
NIA |
2021 |
|
Regulation of Microglial Bioenergetics and Neuroinflammation by Kv1.3 Channels in Alzheimers Disease |
1 F31 AG074665-01 |
|
NIA |
2021 |
|
Novel Acetylated Tau Immunotherapy for Alzheimer's disease |
1 F32 AG072826-01 |
|
NIA |
2021 |
|
Impact of DNA double-strand breaks on 3D genome organization and genome stability in Alzheimer’s disease |
1 K99 AG073466-01 |
|
NIA |
2021 |
|
Project 2: Co-pathogenic Interactions between ApoE Isoforms and Abeta in Neural Network Dysfunction of Alzheimer's Disease |
1 P01 AG073082-01 |
|
NIA |
2021 |
|
Alzheimers Disease Pathology in a Primate Model |
1 R01 AG067419-01A1 |
|
NIA |
2021 |
|
Drug repositioning for Alzheimers disease via genetics, electronic health records, and human iPSC models |
1 R01 AG069900-01 |
|
NIA |
2021 |
|
Mechanisms of pathology and neuronal hyperactivity in a memory circuit in Alzheimer's disease |
1 R01 AG070831-01 |
|
NIA |
2021 |